Total Payments
$6,638
2024 Payments
$714.73
Companies
34
Transactions
424
Medicare Patients
31,933
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$6,604 (99.5%)
Education$34.29 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,604 | 421 | 99.5% |
| Education | $34.29 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,855 | 122 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $695.48 | 57 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $437.20 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $400.74 | 22 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $362.44 | 24 | $0 (2023) |
| Philips Electronics North America Corporation | $331.28 | 21 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $313.28 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $206.87 | 13 | $0 (2022) |
| Amgen Inc. | $204.08 | 14 | $0 (2022) |
| PFIZER INC. | $190.50 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $714.73 | 38 | Actelion Pharmaceuticals US, Inc. ($109.77) |
| 2023 | $667.07 | 44 | Philips Electronics North America Corporation ($188.81) |
| 2022 | $951.38 | 55 | Novartis Pharmaceuticals Corporation ($159.73) |
| 2021 | $1,099 | 74 | Novartis Pharmaceuticals Corporation ($322.09) |
| 2020 | $447.10 | 29 | Novartis Pharmaceuticals Corporation ($231.86) |
| 2019 | $831.11 | 51 | Novartis Pharmaceuticals Corporation ($264.14) |
| 2018 | $963.54 | 69 | Novartis Pharmaceuticals Corporation ($329.27) |
| 2017 | $964.37 | 64 | Novartis Pharmaceuticals Corporation ($398.49) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 2 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: DIABETES | ||||||
| 04/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiology | ||||||
| 04/08/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/28/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: Medical Device | ||||||
| 03/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROLOGY | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Medical Device | ||||||
| 02/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: DIABETES | ||||||
| 01/29/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Medical Device | ||||||
| 11/02/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Medical Device | ||||||
| 10/20/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiology | ||||||
| 10/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/12/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Medical Device | ||||||
| 10/10/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Medical Device | ||||||
| 10/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROLOGY | ||||||
| 09/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| Category: Medical Device | ||||||
| 09/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: DIABETES | ||||||
| 09/06/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology | ||||||
| 08/28/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $23.71 | General |
| Category: Heart Failure and Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 7,048 | 14,945 | $1.6M | $561,717 |
| 2022 | 44 | 7,599 | 14,671 | $1.6M | $552,228 |
| 2021 | 44 | 8,350 | 17,682 | $1.8M | $652,788 |
| 2020 | 45 | 8,936 | 16,381 | $1.8M | $617,875 |
Total Patients
31,933
Total Services
63,679
Medicare Billing
$2.4M
Procedure Codes
179
All Medicare Procedures & Services
179 procedure records from CMS Medicare Utilization — Page 2 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83735 | Magnesium level | Office | 2023 | 290 | 346 | $10,380 | $2,240 | 21.6% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 15 | 20 | $5,056 | $1,501 | 29.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 17 | $3,485 | $1,444 | 41.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 24 | 25 | $2,875 | $1,403 | 48.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 47 | 57 | $3,249 | $1,343 | 41.3% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 360 | 448 | $4,480 | $1,174 | 26.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 12 | $4,202 | $1,155 | 27.5% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2023 | 27 | 164 | $2,460 | $1,035 | 42.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 93 | 105 | $4,200 | $990.08 | 23.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 52 | 57 | $3,705 | $984.85 | 26.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 27 | 28 | $1,596 | $900.51 | 56.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 27 | $1,215 | $767.88 | 63.2% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 12 | 15 | $5,625 | $737.10 | 13.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 32 | 32 | $2,080 | $605.44 | 29.1% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 11 | 11 | $2,210 | $446.22 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 28 | $1,540 | $279.99 | 18.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 13 | 14 | $1,120 | $250.77 | 22.4% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 23 | 2,400 | $2,400 | $248.93 | 10.4% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 15 | 15 | $1,575 | $86.14 | 5.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 17 | $204.00 | $37.40 | 18.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 20 | 23 | $345.00 | $25.44 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 837 | 1,989 | $407,745 | $161,231 | 39.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 276 | 2,113 | $160,588 | $60,135 | 37.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 216 | 315 | $122,850 | $45,473 | 37.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 310 | 314 | $141,300 | $43,396 | 30.7% |
About David Iansmith, MD PHD
David Iansmith, MD PHD is a Cardiovascular Disease healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477585768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Iansmith, MD PHD has received a total of $6,638 in payments from pharmaceutical and medical device companies, with $714.73 received in 2024. These payments were reported across 424 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,604).
As a Medicare-enrolled provider, Iansmith has provided services to 31,933 Medicare beneficiaries, totaling 63,679 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 179 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Memphis, TN
- Active Since 07/07/2006
- Last Updated 03/21/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477585768
Products in Payments
- ENTRESTO (Drug) $1,740
- XARELTO (Drug) $695.48
- Vascepa (Drug) $400.74
- OPSUMIT (Drug) $289.27
- (5044) MCOT (Device) $266.58
- PRALUENT (Drug) $259.74
- ELIQUIS (Drug) $242.26
- JARDIANCE (Drug) $211.70
- LifeVest (Device) $145.84
- LEXISCAN (Drug) $131.37
- VERQUVO (Drug) $116.23
- LEQVIO (Drug) $114.96
- MULTAQ (Drug) $102.70
- PRADAXA (Drug) $101.58
- Repatha (Biological) $94.54
- UPTRAVI (Drug) $91.88
- TEGSEDI (Drug) $89.60
- Livalo (Drug) $88.68
- Corlanor (Drug) $86.54
- BRILINTA (Drug) $84.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Memphis
Dmitry Yaranov, Md, MD
Cardiovascular Disease — Payments: $600,772
Cardiovascular Disease $600,772
Steven Gubin, Md, MD
Cardiovascular Disease — Payments: $401,952
Cardiovascular Disease $401,952
Frank Mcgrew, Md, MD
Cardiovascular Disease — Payments: $231,282
Cardiovascular Disease $231,282
Dwight Dishmon, Md, MD
Cardiovascular Disease — Payments: $210,097
Cardiovascular Disease $210,097
Claro Diaz, Md, MD
Cardiovascular Disease — Payments: $174,401
Cardiovascular Disease $174,401
Stevan Himmelstein, Md, MD
Cardiovascular Disease — Payments: $77,954
Cardiovascular Disease $77,954